{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T04:10:32Z","timestamp":1730175032070,"version":"3.28.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,28]]},"DOI":"10.7759\/cureus.72528","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T11:27:18Z","timestamp":1730114838000},"source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology and Treatment Trends in the Management of Dupuytren's Disease From 2016 to 2022"],"prefix":"10.7759","author":[{"given":"Nathaniel","family":"Pineda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kassem","family":"Ghayyad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler F","family":"Beaudoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meysam","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Zeini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir R","family":"Kachooei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3109\/03008207.2011.642035","article-title":"Fibroproliferative disorders and their mechanobiology","volume":"53","author":"Huang C","year":"2012","unstructured":"Huang C, Ogawa R. Fibroproliferative disorders and their mechanobiology. Connect Tissue Res. 2012, 53:187-96. 10.3109\/03008207.2011.642035","journal-title":"Connect Tissue Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn TA","year":"2008","unstructured":"Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008, 214:199-210. 10.1002\/path.2277","journal-title":"J Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-020-01999-7","article-title":"The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis","volume":"15","author":"Salari N","year":"2020","unstructured":"Salari N, Heydari M, Hassanabadi M, et al.. The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2020, 15:495. 10.1186\/s13018-020-01999-7","journal-title":"J Orthop Surg Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/jhsu.2002.35299","article-title":"Collagen as a clinical target: nonoperative treatment of Dupuytren's disease","volume":"27","author":"Badalamente MA","year":"2002","unstructured":"Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg Am. 2002, 27:788-98. 10.1053\/jhsu.2002.35299","journal-title":"J Hand Surg Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11552-011-9326-8","article-title":"A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture","volume":"6","author":"Chen NC","year":"2011","unstructured":"Chen NC, Srinivasan RC, Shauver MJ, Chung KC. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture. Hand (N Y). 2011, 6:250-5. 10.1007\/s11552-011-9326-8","journal-title":"Hand (N Y)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3928\/01477447-20111122-23","article-title":"Dupuytren's disease","volume":"35","author":"Worrell M","year":"2012","unstructured":"Worrell M. Dupuytren's disease. Orthopedics. 2012, 35:52-60. 10.3928\/01477447-20111122-23","journal-title":"Orthopedics"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2021.07.005","article-title":"Dupuytren contractures: an update of recent literature","volume":"46","author":"Boe C","year":"2021","unstructured":"Boe C, Blazar P, Iannuzzi N. Dupuytren contractures: an update of recent literature. J Hand Surg Am. 2021, 46:896-906. 10.1016\/j.jhsa.2021.07.005","journal-title":"J Hand Surg Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e31823aea95","article-title":"Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy","volume":"129","author":"van Rijssen AL","year":"2012","unstructured":"van Rijssen AL, Ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012, 129:469-77. 10.1097\/PRS.0b013e31823aea95","journal-title":"Plast Reconstr Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0712(21)00439-X","article-title":"Epidemiology of Dupuytren\u2019s disease","volume":"15","author":"Ross DC","year":"1999","unstructured":"Ross DC. Epidemiology of Dupuytren\u2019s disease. Hand Clinics. 1999, 15:53-62. 10.1016\/S0749-0712(21)00439-X","journal-title":"Hand Clinics"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2006.02.021","article-title":"A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study","volume":"31","author":"van Rijssen AL","year":"2006","unstructured":"van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006, 31:717-25. 10.1016\/j.jhsa.2006.02.021","journal-title":"J Hand Surg Am"},{"key":"ref11","article-title":"Comorbidity in Dupuytren disease","volume":"82","author":"Wijnen V","year":"2016","unstructured":"Wijnen V, Buntinix F, De Smet L, Bartholomeeusen S, Degreef I. Comorbidity in Dupuytren disease. Acta Orthop Belg. 2016, 82:643-648.","journal-title":"Acta Orthop Belg"},{"key":"ref12","article-title":"","author":"Wolfe SW","year":"2022","unstructured":"Wolfe SW, Pederson WC, Kozin SH, Cohen MS. Green\u2019s Operative Hand Surgery. Elsevier, Inc, Amsterdam, The Netherlands; 2022. https:\/\/www.us.elsevierhealth.com\/greens-operative-hand-surgery-9780323697934.html?srsltid=AfmBOopxCE8SkS7UZSbstQvP_L...."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.100B9.BJJ-2017-1194.R2","article-title":"Treatment of Dupuytren's contracture: a systematic review","volume":"100-B","author":"Soreide E","year":"2018","unstructured":"Soreide E, Murad MH, Denbeigh JM, et al.. Treatment of Dupuytren's contracture: a systematic review. Bone Joint J. 2018, 100-B:1138-45. 10.1302\/0301-620X.100B9.BJJ-2017-1194.R2","journal-title":"Bone Joint J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13871-8","article-title":"Guillaume Dupuytren and finger contractures","volume":"362","author":"Gudmundsson KG","year":"2003","unstructured":"Gudmundsson KG, J\u00f3nsson T, Arngr\u00edmsson R. Guillaume Dupuytren and finger contractures. The Lancet. 2003, 362:165-168. 10.1016\/S0140-6736(03)13871-8","journal-title":"The Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012943","article-title":"Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability","volume":"7","author":"Lauritzson A","year":"2017","unstructured":"Lauritzson A, Atroshi I. Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability. BMJ Open. 2017, 7:e012943. 10.1136\/bmjopen-2016-012943","journal-title":"BMJ Open"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.19861","article-title":"Cost-effectiveness of recurrent Dupuytren contracture treatment","volume":"3","author":"Yoon AP","year":"2020","unstructured":"Yoon AP, Kane RL, Hutton DW, Chung KC. Cost-effectiveness of recurrent Dupuytren contracture treatment. JAMA Netw Open. 2020, 3:e2019861. 10.1001\/jamanetworkopen.2020.19861","journal-title":"JAMA Netw Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306817-epidemiology-and-treatment-trends-in-the-management-of-dupuytrens-disease-from-2016-to-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T11:27:20Z","timestamp":1730114840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306817-epidemiology-and-treatment-trends-in-the-management-of-dupuytrens-disease-from-2016-to-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.72528","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,28]]}}}